The DOI matches its Crossref record; 428 of the 428 references it cites were found in a registry or an index.
Genetics and biology of pancreatic ductal adenocarcinoma
Open accessAbstract
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer death in the United States with a median survival of <6 mo and a dismal 5-yr survival rate of 3%–5%. The cancer’s lethal nature stems from its propensity to rapidly disseminate to the lymphatic system and distant organs. This aggressive biology and resistance to conventional and targeted therapeutic agents leads to a typical clinical presentation of incurable disease at the time of diagnosis. The well-defined serial histopathologic picture and accompanying molecular profiles of PDAC and its precursor lesions have provided the framework for emerging basic and translational research. Recent advances include insights into the cancer’s cellular origins, high-resolution genomic profiles pointing to potential new therapeutic targets, and refined mouse models reflecting both the genetics and histopathologic evolution of human PDAC. This confluence of developments offers the opportunity for accelerated discovery and the future promise of improved treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 428
Cancer Modeling in the Modern Era
Van Dyke, T., & Jacks, T. (2002) · Cell · doi:10.1016/s0092-8674(02)00621-9 · Cited by 358
Activation of RalA is critical for Ras-induced tumorigenesis of human cells
Lim, K.-H., Baines, A. T., Fiordalisi, J. J., Shipitsin, M., Feig, L. A., Cox, A. D., Der, C. J., & Counter, C. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.04.030 · Cited by 355
Yamanaka, Y., Frieß, H., Büchler, M. W., Beger, H. G., Uchida, E., Onda, M., Kobrin, M. S., & Korc, M. (1993) · PubMed · Cited by 354
The Risk of Cancer among Patients with Cystic Fibrosis
Neglia, J. P., FitzSimmons, S. C., Maisonneuve, P., Schöni, M. H., Schöni-Affolter, F., Corey, M., & Lowenfels, A. B. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502233320803 · Cited by 351
Morphological lesions associated with human primary invasive nonendocrine pancreas cancer.
Cubilla, A. L., & FITZGERALD, P. J. (1976) · PubMed · Cited by 350
(2006) · PubMed · Cited by 347
Thomas, A. M., Santarsiero, L. M., Lutz, E. R., Armstrong, T. D., Chen, Y.-C., Huang, L.-Q., Laheru, D. A., Goggins, M., Hruban, R. H., & Jaffee, E. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031435 · Cited by 347
A meta-analysis of obesity and the risk of pancreatic cancer
de Gonzalez, A. B., Sweetland, S., & Spencer, E. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601140 · Cited by 347
Borg, A., Sandberg, T., Nilsson, K., Johannsson, O., Klinker, M., Masback, A., Westerdahl, J., Olsson, H., & Ingvar, C. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.15.1260 · Cited by 345
Means, A. L., Meszoely, I. M., Suzuki, K., Miyamoto, Y., Rustgi, A. K., Coffey, R. J., Wright, C. V. E., Stoffers, D. A., & Leach, S. D. (2005) · Development · doi:10.1242/dev.01925 · Cited by 344
Levy, L., & Hill, C. S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.18.8108-8125.2005 · Cited by 342
Wilentz, R. E., Geradts, J., Maynard, R. D., Offerhaus, G. J. A., Kang, M., Goggins, M., Yeo, C. J., Kern, S. E., & Hruban, R. H. (1998) · PubMed · Cited by 337
A Prospective Study of Cigarette Smoking and the Risk of Pancreatic Cancer
Fuchs, C. S. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.19.2255 · Cited by 333
Sharma, A., Zangen, D. H., Reitz, P., Taneja, M., Lissauer, M. E., Miller, C. P., Weir, G. C., Habener, J. F., & Bonner-Weir, S. (1999) · Diabetes · doi:10.2337/diabetes.48.3.507 · Cited by 331
Ruggeri, B. A., Huang, L., Wood, M., Cheng, J. Q., & Testa, J. R. (1998) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199802)21:2<81::aid-mc1>3.3.co;2-k · Cited by 329
Löhr, M. J., Schmidt, C., Ringel, J., Kluth, M., Müller, P., Nizze, H., & Jesnowski, R. (2001) · PubMed · Cited by 325
Argani, P., Rosty, C., Reiter, R. E., Wilentz, R. E., Murugesan, S. R., Leach, S. D., Ryu, B., Skinner, H. G., Goggins, M., Jaffee, E. M., et al. (2001) · PubMed · Cited by 313
(2000) · PubMed · Cited by 310
(2001) · PubMed · Cited by 309
Maloney, E. K., McLaughlin, J. L., Dagdigian, N. E., Garrett, L. M., Connors, K. M., Zhou, X., Blättler, W. A., Chittenden, T. D., & Singh, R. (2003) · PubMed · Cited by 307
Bergmann, U., Funatomi, H., Yokoyama, M., Beger, H. G., & Korc, M. (1995) · PubMed · Cited by 304
Asano, T., Yao, Y., Zhu, J., Li, D., Abbruzzese, J. L., & Reddy, S. A. G. (2004) · Oncogene · doi:10.1038/sj.onc.1207902 · Cited by 303
The Superoxide-Generating Oxidase Nox1 Is Functionally Required for Ras Oncogene Transformation
Mitsushita, J., Lambeth, J. D., & Kamata, T. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3909 · Cited by 302
THE RISK OF CANCER AMONG PATIENTS WITH CYSTIC FIBROSIS
Eglia, J. O. P. N., Itz, S. T. C. F., Aisonneuve, P. A. M., et al. (1995) · Cited by 301
Wildtype Kras2 can inhibit lung carcinogenesis in mice
Zhang, Z., Wang, Y., Vikis, H. G., Johnson, L., Liu, G., Li, J., Anderson, M. W., Sills, R. C., Hong, H. L., Devereux, T. R., et al. (2001) · Nature Genetics · doi:10.1038/ng721 · Cited by 296
Phillips, P. A. (2003) · Gut · doi:10.1136/gut.52.2.275 · Cited by 295
Discovery of Novel Tumor Markers of Pancreatic Cancer using Global Gene Expression Technology
Iacobuzio-Donahue, C. A., Maitra, A., Shen-Ong, G. L., van Heek, T., Ashfaq, R., Meyer, R., Walter, K., Berg, K., Hollingsworth, M. A., Cameron, J. L., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62551-5 · Cited by 294
Pten constrains centroacinar cell expansion and malignant transformation in the pancreas
Stanger, B. Z., Stiles, B., Lauwers, G. Y., Bardeesy, N., Mendoza, M., Wang, Y., Greenwood, A., Cheng, K.-H., McLaughlin, M., Brown, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.07.015 · Cited by 294
Self-citationRosty, C., Christa, L., Kuzdzal, S. A., Baldwin, W. M., ZAHURAK, M. L., Carnot, F., Chan, D. W., Canto, M. I., Lillemoe, K. D., Cameron, J. L., et al. (2002) · PubMed · Cited by 292
Precursors to Invasive Pancreatic Cancer
Maitra, A., Fukushima, N., Takaori, K., & Hruban, R. H. (2005) · Advances in Anatomic Pathology · doi:10.1097/01.pap.0000155055.14238.25 · Cited by 291
Itakura, J., Ishiwata, T., Friess, H., Fujii, H., Matsumoto, Y., Büchler, M. W., & Korc, M. (1997) · PubMed · Cited by 291
Andea, A., Sarkar, F., & Adsay, V. N. (2003) · Modern Pathology · doi:10.1097/01.mp.0000087422.24733.62 · Cited by 290
Bonner‐Weir, S., & Sharma, A. (2002) · The Journal of Pathology · doi:10.1002/path.1158 · Cited by 282
Whelan, A. J., Bartsch, D., & Goodfellow, P. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331505 · Cited by 280
Boros, L. G., Puigjaner, J., Cascante, M., Lee, W. N., Brandes, J. L., Bassilian, S., Yusuf, F., Williams, R. D., Muscarella, P., Melvin, W. S., et al. (1997) · PubMed · Cited by 277
High-resolution characterization of the pancreatic adenocarcinoma genome
Aguirre, A. J., Brennan, C., Bailey, G., Sinha, R., Feng, B., Leo, C., Zhang, Y., Zhang, J., Gans, J. D., Bardeesy, N., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402932101 · Cited by 277
Self-citationMutation of the CDKN2A 5' UTR creates an aberrant initiation codon and predisposes to melanoma
Liu, L., Dilworth, D., Gao, L., Monzon, J., Summers, A., Lassam, N., & Hogg, D. (1999) · Nature Genetics · doi:10.1038/5082 · Cited by 276
Abraham, S. C., Wu, T.-T., Klimstra, D. S., Finn, L. S., Lee, J.-H., Yeo, C. J., Cameron, J. L., & Hruban, R. H. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63008-8 · Cited by 275
Nucleolar Arf Tumor Suppressor Inhibits Ribosomal RNA Processing
Sugimoto, M., Kuo, M.-L., Roussel, M. F., & Sherr, C. J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00057-1 · Cited by 273
Sato, N., Rosty, C., Jansen, M., Fukushima, N., Ueki, T., Yeo, C. J., Cameron, J. L., Iacobuzio-Donahue, C. A., Hruban, R. H., & Goggins, M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63053-2 · Cited by 267
Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis
Schwarte-Waldhoff, I., Volpert, O. V., Bouck, N. P., Sipos, B., Hahn, S. A., Klein-Scory, S., Lüttges, J., Klöppel, G., Graeven, U., Eilert-Micus, C., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9624 · Cited by 266
Strobel, O., Dor, Y., Alsina, J., Stirman, A., Lauwers, G., Trainor, A., Castillo, C. F., Warshaw, A. L., & Thayer, S. P. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.09.009 · Cited by 266
Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer.
Renzo, M. F. D., Poulsom, R., Olivero, M., et al. (1995) · PubMed · Cited by 262
Pancreatic neoplasia induced by ras expression in acinar cells of transgenic mice
Quaife, C. J., Pinkert, C. A., Ornitz, D. M., Palmiter, R. D., & Brinster, R. L. (1987) · Cell · doi:10.1016/0092-8674(87)90710-0 · Cited by 262
Incidence, mechanism and prognostic value of activated AKT in pancreas cancer
Schlieman, M. G., Fahy, B. N., Ramsamooj, R., Beckett, L., & Bold, R. J. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601396 · Cited by 260
Decreased Total Lymphocyte Counts in Pancreatic Cancer: An Index of Adverse Outcome
Fogar, P., Sperti, C., Basso, D., Sanzari, M. C., Greco, E., Davoli, C., Navaglia, F., Zambon, C.-F., Pasquali, C., Venza, E., et al. (2006) · Pancreas · doi:10.1097/01.mpa.0000188305.90290.50 · Cited by 260
Nakamura, T., Furukawa, Y., Nakagawa, H., Tsunoda, T., Ohigashi, H., Murata, K., Ishikawa, O., Ohgaki, K., Kashimura, N., Miyamoto, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207392 · Cited by 260
New roles for the LKB1→AMPK pathway
Hardie, D. G. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.01.006 · Cited by 255
Hald, J., Hjorth, J. P., German, M. S., Madsen, O. D., Serup, P., & Jensen, J. (2003) · Developmental Biology · doi:10.1016/s0012-1606(03)00326-9 · Cited by 251
Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas
Ouban, A., Muraca, P., Yeatman, T., & Coppola, D. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00291-0 · Cited by 251
Sharpless, N. E., & DePinho, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00818-8 · Cited by 250
Self-citationDivergent Roles for RalA and RalB in Malignant Growth of Human Pancreatic Carcinoma Cells
Lim, K.-H., O'Hayer, K., Adam, S. J., Kendall, S. D., Campbell, P. M., Der, C. J., & Counter, C. M. (2006) · Current Biology · doi:10.1016/j.cub.2006.10.023 · Cited by 250
Ki-ras oncogene activation in preinvasive pancreatic cancer
Lemoine, N. R., Jain, S., Hughes, C. M., Staddon, S. L., Maillet, B., Hall, P. A., & Klöppel, G. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91805-e · Cited by 249
Ral-GTPases: approaching their 15 minutes of fame.
Feig, L. A. (2003) · Trends in Cell Biology · doi:10.1016/s0962-8924(03)00152-1 · Cited by 249
Telomere dysfunction provokes regional amplification and deletion in cancer genomes
O'Hagan, R. C., Chang, S., Maser, R. S., Mohan, R., Artandi, S. E., Chin, L., & DePinho, R. A. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00094-6 · Cited by 246
Self-citationPrasad, N. B., Biankin, A. V., Fukushima, N., Maitra, A., Dhara, S., Elkahloun, A. G., Hruban, R. H., Goggins, M., & Leach, S. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1413 · Cited by 242
Lüttges, J., Galehdari, H., Bröcker, V., Schwarte-Waldhoff, I., Henne-Bruns, D., Klöppel, G., Schmiegel, W., & Hahn, S. A. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64123-5 · Cited by 241
Pancreatic Neoplasia Induced by SV40 T-Antigen Expression in Acinar Cells of Transgenic Mice
Ornitz, D. M., Hammer, R. E., Messing, A., Palmiter, R. D., & Brinster, R. L. (1987) · Science · doi:10.1126/science.2821617 · Cited by 241
Rho GTPase expression in tumourigenesis: Evidence for a significant link
del Pulgar, T. G., Benitah, S. A., Valerón, P. F., Espina, C., & Lacal, J. C. (2005) · BioEssays · doi:10.1002/bies.20238 · Cited by 240
Lerner, E. C., Zhang, T.-T., Knowles, D. B., Qian, Y., Hamilton, A. D., & Sebti, S. M. (1997) · Oncogene · doi:10.1038/sj.onc.1201296 · Cited by 239
Familial pancreatic cancer: a review.
Lynch, H. T., Smyrk, T. C., Kern, S. E., Hruban, R. H., Lightdale, C. J., Lemon, S. J., Lynch, J. F., Fusaro, L., Fusaro, R. M., & Ghadirian, P. (1996) · PubMed · Cited by 239
Cancer therapy: can the challenge be MET?
Corso, S., Comoglio, P. M., & Giordano, S. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.04.005 · Cited by 238
β-Catenin is essential for pancreatic acinar but not islet development
Murtaugh, L. C., Law, A. C., Dor, Y., & Melton, D. A. (2005) · Development · doi:10.1242/dev.02063 · Cited by 238
Genes, Signals, and Lineages in Pancreas Development
Murtaugh, L. C., & Melton, D. A. (2003) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.19.111301.144752 · Cited by 238
Significant Role for p16INK4a in p53-Independent Telomere-Directed Senescence
Jacobs, J. J. L., & de Lange, T. (2004) · Current Biology · doi:10.1016/j.cub.2004.12.025 · Cited by 237
BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) Mutations in Distinct Subsets of Pancreatic Cancer
Calhoun, E. S., Jones, J. B., Ashfaq, R., Adsay, V., Baker, S. J., Valentine, V., Hempen, P. M., Hilgers, W., Yeo, C. J., Hruban, R. H., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63485-2 · Cited by 232
Aneuploidy, the somatic mutation that makes cancer a species of its own
Duesberg, P., & Rasnick, D. (2000) · Cell Motility · doi:10.1002/1097-0169(200010)47:2<81::aid-cm1>3.0.co;2-# · Cited by 229
Direct lineage tracing reveals the ontogeny of pancreatic cell fates during mouse embryogenesis
Gu, G., Brown, J. R., & Melton, D. A. (2003) · Mechanisms of Development · doi:10.1016/s0925-4773(02)00330-1 · Cited by 227
Expression profiling of microdissected pancreatic adenocarcinomas
Crnogorac-Jurcevic, T., Efthimiou, E., Nielsen, T., Loader, J., Terris, B., Stamp, G., Baron, A., Scarpa, A., & Lemoine, N. R. (2002) · Oncogene · doi:10.1038/sj.onc.1205570 · Cited by 225
Lynch, H. T., Brand, R. E., Hogg, D., Deters, C. A., Fusaro, R. M., Lynch, J. F., Liu, L., Knezetic, J., Lassam, N. J., Goggins, M., et al. (2002) · Cancer · doi:10.1002/cncr.10159 · Cited by 222
Strober, S. (1984) · Annual Review of Immunology · doi:10.1146/annurev.iy.02.040184.001251 · Cited by 222
Lebowitz, P. F., Davide, J. P., & Prendergast, G. C. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.12.6613 · Cited by 221
Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis
Fernandez-Zapico, M. E., Gonzalez-Paz, N. C., Weiss, E., Savoy, D. N., Molina, J. R., Fonseca, R., Smyrk, T. C., Chari, S. T., Urrutia, R., & Billadeau, D. D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.024 · Cited by 221
INK4a‐deficient human diploid fibroblasts are resistant to RAS‐induced senescence
Brookes, S., Rowe, J., Ruas, M., Llanos, S., Clark, P. A., Lomax, M., James, M. C., Vatcheva, R., Bates, S., Vousden, K. H., et al. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf289 · Cited by 220
Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas
Suwa, H., Ohshio, G., Imamura, T., Watanabe, G., Arii, S., Imamura, M., Narumiya, S., Hiai, H., & Fukumoto, M. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.23 · Cited by 218
Function of nuclear factor kappaB in pancreatic cancer metastasis.
Fujioka, S., Sclabas, G. M., Schmidt, C., Frederick, W., Dong, Q. G., Abbruzzese, J. L., Evans, D. B., Baker, C. H., & Chiao, P. J. (2003) · PubMed · Cited by 218
Hart, A., Papadopoulou, S., & Edlund, H. (2003) · Developmental Dynamics · doi:10.1002/dvdy.10368 · Cited by 216
Esni, F., Ghosh, B., Biankin, A. V., Lin, J. W., Albert, M. A., Yu, X., MacDonald, R. J., Civin, C. I., Real, F. X., Pack, M. A., et al. (2004) · Development · doi:10.1242/dev.01280 · Cited by 216
Jaffee, E. M., Hruban, R. H., Canto, M., & Kern, S. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00093-4 · Cited by 215
Norgaard, G. A., Jensen, J. N., & Jensen, J. (2003) · Developmental Biology · doi:10.1016/j.ydbio.2003.08.013 · Cited by 214
p19ARF directly and differentially controls the functions of c-Myc independently of p53
Qi, Y., Gregory, M. A., Li, Z., Brousal, J. P., West, K., & Hann, S. R. (2004) · Nature · doi:10.1038/nature02958 · Cited by 214
BRCA2 Is Inactivated Late in the Development of Pancreatic Intraepithelial Neoplasia
Goggins, M., Hruban, R. H., & Kern, S. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65047-x · Cited by 212
Foulis, A. K. (1998) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199806)185:2<227::aid-path103>3.0.co;2-r · Cited by 212
Bellone, G., Smirne, C., Mauri, F. A., Tonel, E., Carbone, A., Buffolino, A., Dughera, L., Robecchi, A., Pirisi, M., & Emanuelli, G. (2006) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-005-0047-0 · Cited by 209
Grippo, P. J., Nowlin, P. S., Demeure, M. J., Longnecker, D. S., & Sandgren, E. P. (2003) · PubMed · Cited by 208
Wagner, M., Greten, F. R., Weber, C. K., Koschnick, S., Mattfeldt, T., Deppert, W., Kern, H., Adler, G., & Schmid, R. M. (2001) · Genes & Development · doi:10.1101/gad.184701 · Cited by 207
Sato, N., Fukushima, N., Maitra, A., Iacobuzio-Donahue, C. A., van Heek, N. T., Cameron, J. L., Yeo, C. J., Hruban, R. H., & Goggins, M. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63178-1 · Cited by 205
Immunotherapy for pancreatic cancer — science driving clinical progress
Laheru, D., & Jaffee, E. M. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1630 · Cited by 202
Bashyam, M. D., Bair, R., Kim, Y. H., Wang, P., Hernandez-Boussard, T., Karikari, C. A., Tibshirani, R., Maitra, A., & Pollack, J. R. (2005) · Neoplasia · doi:10.1593/neo.04586 · Cited by 201
K-ras mutations in pancreatic ductal proliferative lesions.
Klimstra, D. S., & Longnecker, D. S. (1994) · PubMed · Cited by 199
Zimny, M., Bares, R., Fa�, J., Adam, G., Cremerius, U., Dohmen, B., Klever, P., Sabri, O., Schumpelick, V., & Buell, U. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf00841409 · Cited by 198
WAGNER, M., LUHRS, H., KLOPPEL, G., ADLER, G., & SCHMID, R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70098-8 · Cited by 193
RAL GTPases are linchpin modulators of human tumour‐cell proliferation and survival
Chien, Y., & White, M. A. (2003) · EMBO reports · doi:10.1038/sj.embor.embor899 · Cited by 193
The love–hate relationship between Ras and Notch
Sundaram, M. V. (2005) · Genes & Development · doi:10.1101/gad.1330605 · Cited by 192
Genotype-Phenotype Relationships in U.S. Melanoma-Prone Families With CDKN2A and CDK4 Mutations
Goldstein, A. M. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.12.1006 · Cited by 192
Brembeck, F. H., Schreiber, F. S., Deramaudt, T. B., Craig, L. E., Rhoades, B., Swain, G. P., Grippo, P. J., Stoffers, D. A., Silberg, D. G., & Rustgi, A. K. (2003) · PubMed · Cited by 190
p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor Suppressor
Rocha, S., Campbell, K. J., & Perkins, N. D. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00223-5 · Cited by 189
Marschall, Z. V., Cramer, T., Höcker, M., Burde, R., Plath, T., Schirner, M., Heidenreich, R., Breier, G., Riecken, E., Wiedenmann, B., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.19578 · Cited by 189
Notch signaling: the demise of elegant simplicity
Kadesch, T. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.07.007 · Cited by 180
Fleming, J. B., Shen, G.-L., Holloway, S. E., Davis, M., & Brekken, R. A. (2005) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-04-0206 · Cited by 176
Sharpless, N. E., Ferguson, D. O., O'Hagan, R. C., Castrillon, D. H., Lee, C., Farazi, P. A., Alson, S., Fleming, J., Morton, C. C., Frank, K., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00425-7 · Cited by 175
Self-citationStoeltzing, O., Liu, W., Reinmuth, N., Fan, F., Parikh, A. A., Bucana, C. D., Evans, D. B., Semenza, G. L., & Ellis, L. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63460-8 · Cited by 175
Frequent amplification of 8q24, 11q, 17q, and 20q‐specific genes in pancreatic cancer
Mahlamäki, E. H., Bärlund, M., Tanner, M., Gorunova, L., Höglund, M., Karhu, R., & Kallioniemi, A. (2002) · Genes, Chromosomes and Cancer · doi:10.1002/gcc.10122 · Cited by 175
Frequent activation of AKT2 kinase in human pancreatic carcinomas
Altomare, D. A., Tanno, S., De Rienzo, A., Klein‐Szanto, A. J., Tanno, S., Skele, K. L., Hoffman, J. P., & Testa, J. R. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10287 · Cited by 174
Molecular regulation of pancreatic stellate cell function.
Jaster, R. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-26 · Cited by 173
Mitogenic and antiapoptotic role of constitutive NF‐κB/Rel activity in pancreatic cancer
Liptay, S., Weber, C. K., Ludwig, L., Wagner, M., Adler, G., & Schmid, R. M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11081 · Cited by 172
Siveke, J. T., Einwächter, H., Sipos, B., Lubeseder–Martellato, C., Klöppel, G., & Schmid, R. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.002 · Cited by 170
Ezernitchi, A. V., Vaknin, I., Cohen-Daniel, L., Levy, O., Manaster, E., Halabi, A., Pikarsky, E., Shapira, L., & Baniyash, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.7.4763 · Cited by 169
Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues.
Nielsen, G. P., Stemmer-Rachamimov, A. O., Shaw, J., Roy, J. E., Koh, J., & Louis, D. N. (1999) · PubMed · Cited by 169
Dong, Q. G., Sclabas, G. M., Fujioka, S., Schmidt, C., Peng, B., Wu, T., Tsao, M.-S., Evans, D. B., Abbruzzese, J. L., McDonnell, T. J., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205848 · Cited by 166
Missiaglia, E., Blaveri, E., Terris, B., Wang, Y., Costello, E., Neoptolemos, J. P., Crnogorac‐Jurcevic, T., & Lemoine, N. R. (2004) · International Journal of Cancer · doi:10.1002/ijc.20376 · Cited by 164
Dessimoz, J., Bonnard, C., Huelsken, J., & Grapin-Botton, A. (2005) · Current Biology · doi:10.1016/j.cub.2005.08.037 · Cited by 164
PIK3CA Mutations in Intraductal Papillary Mucinous Neoplasm/Carcinoma of the Pancreas
Schönleben, F., Qiu, W., Ciau, N. T., Ho, D. J., Li, X., Allendorf, J. D., Remotti, H. E., & Su, G. H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0292 · Cited by 164
Tomioka, D., Maehara, N., Kuba, K., Mizumoto, K., Tanaka, M., Matsumoto, K., & Nakamura, T. (2001) · PubMed · Cited by 164
Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors.
Okami, K., Wu, L. J., Riggins, G. J., Cairns, P., Goggins, M., Evron, E., Halachmi, N., Ahrendt, S. A., Reed, A. L., Hilgers, W., et al. (1998) · PubMed · Cited by 163
DPC4/Smad4 Expression and Outcome in Pancreatic Ductal Adenocarcinoma
Biankin, A. V., Morey, A. L., Lee, C.-S., Kench, J. G., Biankin, S. A., Hook, H. C., Head, D. R., Hugh, T. B., Sutherland, R. L., & Henshall, S. M. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.063 · Cited by 163
Sato, N., Fukushima, N., Matsubayashi, H., & Goggins, M. (2004) · Oncogene · doi:10.1038/sj.onc.1207269 · Cited by 162
Frieß, H., Yamanaka, Y., Büchler, M. W., Berger, H. G., Kobrin, M. S., Baldwin, R. L., & Korc, M. (1993) · PubMed · Cited by 162
Genetic Progression and Divergence in Pancreatic Carcinoma
Yamano, M., Fujii, H., Takagaki, T., Kadowaki, N., Watanabe, H., & Shirai, T. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65083-3 · Cited by 160
Sharpless, N. E., & DePinho, R. A. (2005) · Nature · doi:10.1038/436636a · Cited by 159
Self-citationLim, K.-H., & Counter, C. M. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.014 · Cited by 159
Induction and expression of amphiregulin in human pancreatic cancer.
Ebert, M. P., Yokoyama, M., Kobrin, M. S., Friess, H., Lopez, M. E., Büchler, M. W., Johnson, G. R., & Korc, M. (1994) · PubMed · Cited by 156
Pancreatic tumor pathogenesis reflects the causative genetic lesion.
Sandgren, E. P., Quaife, C. J., Paulovich, A. G., Palmiter, R. D., & Brinster, R. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.93 · Cited by 156
Familial Risk of Pancreatic Cancer
Schenk, M., Schwartz, A. G., O'Neal, E., Kinnard, M. F., Greenson, J. K., Fryzek, J. P., Ying, G., & Garabrant, D. H. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.8.640 · Cited by 156
Gysin, S., Lee, S., Dean, N. M., & McMahon, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2848 · Cited by 149
Ellenrieder, V., Hendler, S. F., Ruhland, C., Boeck, W., Adler, G., & Gress, T. M. (2001) · International Journal of Cancer · doi:10.1002/ijc.1330 · Cited by 146
Aneuploidy: a matter of bad connections
Cimini, D., & Degrassi, F. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.06.008 · Cited by 146
Friess, H., Berberat, P. O., Schilling, M. K., Kunz, J., Büchler, M. W., & Korc, M. (1996) · Journal of Molecular Medicine · doi:10.1007/bf00202070 · Cited by 146
Lüttges, J., Schlehe, B., Menke, M. A. O. H., Vogel, I., Henne‐Bruns, D., & Klöppel, G. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990415)85:8<1703::aid-cncr9>3.3.co;2-i · Cited by 145
Activated oncogenes promote and cooperate with chromosomal instability for neoplastic transformation
Woo, R. A., & Poon, R. Y. C. (2004) · Genes & Development · doi:10.1101/gad.1165204 · Cited by 144
The Notch pathway in cancer: Differentiation gone awry
Sjölund, J., Manetopoulos, C., Stockhausen, M., & Axelson, H. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.06.025 · Cited by 144
Bellone, G., Carbone, A., Smirne, C., Scirelli, T., Buffolino, A., Novarino, A., Stacchini, A., Bertetto, O., Palestro, G., Sorio, C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3448 · Cited by 143
Lee, J., Jang, K., Ki, C., Lim, T., Park, Y. S., Lim, H. Y., Choi, D., Kang, W. K., Park, K., & Park, J. O. (2007) · Cancer · doi:10.1002/cncr.22559 · Cited by 142
Holzmann, K., Kohlhammer, H., Schwäenen, C., Weßendorf, S., Kestler, H. A., Schwoerer, A., Rau, B., Radlwimmer, B., Döhner, H., Lichter, P., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0431 · Cited by 142
LKB1 (XEEK1) regulates Wnt signalling in vertebrate development
Ossipova, O., Bardeesy, N. M., DePinho, R. A., & Green, J. B. A. (2003) · Nature Cell Biology · doi:10.1038/ncb1048 · Cited by 141
Self-citationAberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas.
Kobrin, M. S., Yamanaka, Y., Friess, H., Lopez, M. E., & Korc, M. (1993) · PubMed · Cited by 138
Role of Tumor Endothelium in CD4+CD25+ Regulatory T Cell Infiltration of Human Pancreatic Carcinoma
Nummer, D., Suri‐Payer, E., Schmitz‐Winnenthal, H., Bonertz, A., Galindo, L., Antolovic, D., Koch, M., Büchler, M., Weitz, J., Schirrmacher, V., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm064 · Cited by 137
Second nature: Biological functions of the Raf‐1 “kinase”
Baccarini, M. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.024 · Cited by 136
Tuveson, D. A., Zhu, L., Gopinathan, A., Willis, N. A., Kachatrian, L., Mishuris, R. G., Pin, C. L., Mitin, N., Taparowsky, E. J., Gimotty, P. A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2305 · Cited by 136
The interaction of Ras with GTPase‐activating proteins
Wittinghofer, A., Scheffzek, K., & Ahmadian, M. R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00321-9 · Cited by 135
Glycolysis and methylaminoisobutyrate uptake in rat-1 cells transfected with ras or myc oncogenes.
Racker, E., Resnick, R. J., & Feldman, R. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.11.3535 · Cited by 135
Gorunova, L., Höglund, M., Andrén‐Sandberg, Å., Dawiskiba, S., Jin, Y., Mitelman, F., & Johansson, B. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199810)23:2<81::aid-gcc1>3.0.co;2-0 · Cited by 135
Sandgren, E. P., Luetteke, N., Qiu, T. H., Palmiter, R. D., Brinster, R. L., & Lee, D. C. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.1.320-330.1993 · Cited by 135
Uhlirova, M., Jasper, H., & Bohmann, D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504170102 · Cited by 134
Arsura, M., Mercurio, F., Oliver, A. L., Thorgeirsson, S. S., & Sonenshein, G. E. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.15.5381-5391.2000 · Cited by 134
Hepatocyte growth factor and Met receptor expression in human pancreatic carcinogenesis.
Furukawa, T., Duguid, W. P., Kobari, M., Matsuno, S., & Tsao, M. (1995) · Europe PMC (PubMed Central) · Cited by 133
A New Susceptibility Locus for Autosomal Dominant Pancreatic Cancer Maps to Chromosome 4q32-34
Eberle, M. A., Pfützer, R. H., Pogue-Geile, K. L., Bronner, M. P., Crispin, D. A., Kimmey, M. B., Duerr, R. H., Kruglyak, L., Whitcomb, D. C., & Brentnall, T. A. (2002) · The American Journal of Human Genetics · doi:10.1086/339692 · Cited by 132
Functional Defects in the Fanconi Anemia Pathway in Pancreatic Cancer Cells
van der Heijden, M. S., Brody, J. R., Gallmeier, E., Cunningham, S. C., Dezentjé, D. A., Shen, D., Hruban, R. H., & Kern, S. E. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63329-9 · Cited by 129
Centrosome abnormalities in pancreatic ductal carcinoma.
Sato, N., Mizumoto, K., Nakamura, M., Nakamura, K., Kusumoto, M., Niiyama, H., Ogawa, T., & Tanaka, M. (1999) · PubMed · Cited by 126
Hustinx, S. R., Leoni, L. M., Yeo, C. J., Brown, P. N., Goggins, M., Kern, S. E., Hruban, R. H., & Maitra, A. (2005) · Modern Pathology · doi:10.1038/modpathol.3800377 · Cited by 125
Malats, N., Casals, T., Porta, M. S., Guarner, L., Estivill, X., & Real, F. X. (2001) · Gut · doi:10.1136/gut.48.1.70 · Cited by 124
The Molecular Pathology of Pancreatic Cancer
Lemoine, N. R. (1993) · Springer eBooks · doi:10.1007/978-3-642-77437-9_63 · Cited by 123
Kiaris, H., Politi, K. A., Grimm, L. M., Szabolcs, M. J., Fisher, P. E., Efstratiadis, A., & Artavanis‐Tsakonas, S. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63333-0 · Cited by 123
NF‐κB activity blockade impairs the angiogenic potential of human pancreatic cancer cells
Xiong, H. Q., Abbruzzese, J. L., Lin, E. H., Wang, L., Zheng, L., & Xie, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11562 · Cited by 122
Fukasawa, M., & Korc, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0820 · Cited by 122
Genome-wide aberrations in pancreatic adenocarcinoma
Nowak, N. J., Gaile, D. P., Conroy, J. M., McQuaid, D., Cowell, J. K., Carter, R. L., Goggins, M., Hruban, R. H., & Maitra, A. (2005) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2005.01.009 · Cited by 122
Mahlamäki, E., Höglund, M., Gorunova, L., Karhu, R., Dawiskiba, S., Andrén‐Sandberg, Å., Kallioniemi, O., & Johansson, B. (1997) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199712)20:4<383::aid-gcc10>3.0.co;2-o · Cited by 121
Heinmöller, E., Dietmaier, W., Zirngibl, H., Heinmöller, P., Scaringe, W., Jauch, K.-W., Hofstädter, F., & Rüschoff, J. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64520-8 · Cited by 121
Gene expression profiles of microdissected pancreatic ductal adenocarcinoma
Gr�tzmann, R., Foerder, M., Alldinger, I., Staub, E., Br�mmendorf, T., R�pcke, S., Li, X., Kristiansen, G., Jesnowski, R., Sipos, B., et al. (2003) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0884-1 · Cited by 118
Loss of Stk11/Lkb1 Expression in Pancreatic and Biliary Neoplasms
Sahin, F., Maitra, A., Argani, P., Sato, N., Maehara, N., Montgomery, E. A., Goggins, M., Hruban, R. H., & Su, G. H. (2003) · Modern Pathology · doi:10.1097/01.mp.0000075645.97329.86 · Cited by 118
Lewis, B. C., Klimstra, D. S., & VARMUS, H. E. (2003) · Genes & Development · doi:10.1101/gad.1140403 · Cited by 118
Ral GTPases: corrupting the exocyst in cancer cells
Camonis, J., & White, M. A. (2005) · Trends in Cell Biology · doi:10.1016/j.tcb.2005.04.002 · Cited by 117
Targeting of C-Terminal Binding Protein (CtBP) by ARF Results in p53-Independent Apoptosis
Paliwal, S., Pande, S., Kovi, R. C., Sharpless, N. E., Bardeesy, N. M., & Grossman, S. R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2360-2372.2006 · Cited by 117
Self-citationMüerköster, S. S., Arlt, A., Sipos, B., Witt, M., Großmann, M., Klöppel, G., Kalthoff, H., Fölsch, U. R., & Schäfer, H. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1626 · Cited by 116
Expression of p53 protein in precursor lesions and adenocarcinoma of human pancreas.
Boschman, C. R., Stryker, S. J., Reddy, J. K., & Rao, M. S. (1994) · PubMed Central · Cited by 115
Bruns, C. J., Koehl, G. E., Guba, M. O., Yezhelyev, M., Steinbauer, M. G. M., Seeliger, H., Schwend, A., Hoehn, A., Jauch, K., & Geissler, E. K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0502 · Cited by 115
Involvement of the INK4a/Arf gene locus in senescence
Collins, C. J., & Sedivy, J. M. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00048.x · Cited by 113
Wnt5 signaling in vertebrate pancreas development
Kim, H. J., Schleiffarth, J. R., Jessurun, J., Sumanas, S., Petryk, A., Lin, S., & Ekker, S. C. (2005) · BMC Biology · doi:10.1186/1741-7007-3-23 · Cited by 109
Duda, D. G., Sunamura, M., Lefter, L. P., Furukawa, T., Yokoyama, T., Yatsuoka, T., Abe, T., Inoue, H., Motoi, F., Egawa, S., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206751 · Cited by 107
Ductal metaplasia of human exocrine pancreas and its association with carcinoma.
Parsa, I., Longnecker, D. S., Scarpelli, D. G., Pour, P. M., Reddy, J. K., & Lefkowitz, M. (1985) · PubMed · Cited by 103
Normal Human Fibroblasts Are Resistant to RAS-Induced Senescence
Benanti, J. A., & Galloway, D. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.7.2842-2852.2004 · Cited by 103
Sato, N., Mizumoto, K., Nakamura, M., Maehara, N., Minamishima, Y. A., Nishio, S., Nagai, E., & Tanaka, M. (2001) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(00)00384-8 · Cited by 101
Pancreatic Cancer Cell Proliferation Is Phosphatidylinositol 3-Kinase Dependent
Perugini, R. A., McDade, T. P., Vittimberga, F. J., & Callery, M. P. (2000) · Journal of Surgical Research · doi:10.1006/jsre.2000.5833 · Cited by 100
Kornmann, M., Ishiwata, T., Beger, H. G., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201307 · Cited by 100
Heterogenic Loss of the Wild-Type BRCA Allele in Human Breast Tumorigenesis
King, T. A., Li, W., Brogi, E., Yee, C. J., Gemignani, M. L., Olvera, N., Levine, D. A., Norton, L., Robson, M. E., Offit, K., et al. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9372-1 · Cited by 99
Transforming growth factor-β pathway: Role in pancreas development and pancreatic disease
Rane, S. G., Lee, J., & LIN, H. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.003 · Cited by 98
Drayton, S., Rowe, J., Jones, R., Vatcheva, R., Heavens, D., Marshall, J. F., Fried, M., & Peters, G. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00242-3 · Cited by 98
Agbunag, C., & Bar‐Sagi, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0807 · Cited by 96
PDX-1 and Msx-2 expression in the regenerating and developing pancreas
Kritzik, M. R., Jones, E. M., Chen, Z., Krakowski, M. L., Krahl, T., Good, A., Wright, C. V. E., Fox, H. S., & Sarvetnick, N. (1999) · Journal of Endocrinology · doi:10.1677/joe.0.1630523 · Cited by 95
Rowland‐Goldsmith, M., Maruyama, H., Kusama, T., Ralli, S., & Korc, M. (2001) · PubMed · Cited by 93
Rowland‐Goldsmith, M., Maruyama, H., Matsuda, K., Idezawa, T., Ralli, M., Ralli, S., & Korc, M. (2002) · PubMed · Cited by 92
Wang, R. N., Rehfeld, J. F., Nielsen, F. C., & Klöppel, G. (1997) · Diabetologia · doi:10.1007/s001250050764 · Cited by 89
Heidenblad, M., Schoenmakers, E., Jonson, T., Gorunova, L., Veltman, J. A., van Kessel, A. G., & Höglund, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3159 · Cited by 89
Schleger, C., Arens, N., Zentgraf, H., Bleyl, U., & Verbeke, C. S. (2000) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(200005)191:1<27::aid-path582>3.0.co;2-j · Cited by 87
Contribution of p16INK4a to replicative senescence of human fibroblasts
Brookes, S., Rowe, J., del Arroyo, A. G., BOND, J. A., & Peters, G. G. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.04.035 · Cited by 85
Wagner, M., Kleeff, J. H., Frieß, H., Büchler, M. W., & Korc, M. (1999) · Pancreas · doi:10.1097/00006676-199911000-00008 · Cited by 83
Harada, T., Okita, K., Shiraishi, K., Kusano, N., Kondoh, S., & Sasaki, K. (2002) · PubMed · Cited by 81
Role of Epidermal Growth Factor Receptor Signaling in RAS-Driven Melanoma
Bardeesy, N. M., Kim, M., Xu, J., Kim, R.-S., Shen, Q. “., Bosenberg, M., Wong, W. H., & Chin, L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4176-4188.2005 · Cited by 81
Self-citationJohnston, F. M., Tan, M. C. B., Tan, B. R., Porembka, M. R., Brunt, E. M., Linehan, D. C., Simon, P. O., Plambeck-Suess, S. M., Eberlein, T. J., Hellström, K. E., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0565 · Cited by 81
Growth Factor Receptors Are Differentially Expressed in Cancers of the Papilla of Vater and Pancreas
Frieß, H., Wang, L., Zhu, Z., Gerber, R., Schröder, M., Fukuda, A., Zimmermann, A., Korc, M., & Büchler, M. W. (1999) · Annals of Surgery · doi:10.1097/00000658-199912000-00005 · Cited by 79
Obligate Roles for p16 Ink4a and p19 Arf -p53 in the Suppression of Murine Pancreatic Neoplasia
Bardeesy, N. M., Morgan, J. A., Sinha, M., Signoretti, S., Srivastava, S., Loda, M. F., Merlino, G. T., & DePinho, R. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.635-643.2002 · Cited by 79
Self-citationHoshida, T., Sunamura, M., Duda, D. G., Egawa, S., Miyazaki, S., Shineha, R., Hamada, H., Ohtani, H., Satomi, S., & Matsuno, S. (2002) · Pancreas · doi:10.1097/00006676-200208000-00001 · Cited by 78
Mechanism of sensitivity of cultured pancreatic carcinoma to asparaginase
Wu, M., Arimura, G. K., & Yunis, A. A. (1978) · International Journal of Cancer · doi:10.1002/ijc.2910220615 · Cited by 77
Rodríguez, P. C., & Ochoa, A. C. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.10.001 · Cited by 76
Ogawa, T., Takayama, K., Takakura, N., Kitano, S., & Ueno, H. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700478 · Cited by 76
The rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation.
Asano, T., Yao, Y.-X., Zhu, J.-J., Li, D.-H., Abbruzzese, J., & Reddy, S. A. (2005) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2005.03.166 · Cited by 74
Laghi, L., Orbetegli, O., Bianchi, P. P., Zerbi, A., Carlo, V. D., Boland, C. R., & Malesci, A. (2002) · Oncogene · doi:10.1038/sj.onc.1205533 · Cited by 71
BRAF and K-ras gene mutations in human pancreatic cancers
Ishimura, N., Yamasawa, K., Rumi, M. A. K., et al. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00384-7 · Cited by 70
K-Ras Mutations and Benign Pancreatic Disease
Löhr, M. J., Maisonneuve, P., & Lowenfels, A. B. (2000) · International Journal of Gastrointestinal Cancer · doi:10.1385/ijgc:27:2:093 · Cited by 68
Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas
Ohta, T., Yamamoto, M., Numata, M., Iseki, S., Tsukioka, Y., Miyashita, T., Kayahara, M., Nagakawa, T., Miyazaki, I., Nishikawa, K., et al. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.420 · Cited by 68
Cited by
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Kamerkar, S., LeBleu, V. S., Sugimoto, H., Yang, S., Ruivo, C. F., Melo, S. A., Lee, J. J., & Kalluri, R. (2017) · Nature · doi:10.1038/nature22341 · Cited by 2,639
EMT and Dissemination Precede Pancreatic Tumor Formation
Rhim, A. D., Mirek, E. T., Aiello, N. M., Maitra, A., Bailey, J. M., McAllister, F., Reichert, M., Beatty, G. L., Rustgi, A. K., Vonderheide, R. H., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.025 · Cited by 2,136
Self-citationOncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism
Ying, H., Kimmelman, A. C., Lyssiotis, C. A., Hua, S., Chu, G. C., Fletcher-Sananikone, E., Locasale, J. W., Son, J., Zhang, H., Coloff, J. L., et al. (2012) · Cell · doi:10.1016/j.cell.2012.01.058 · Cited by 2,043
Self-citationKleeff, J., Korc, M., Apte, M., La Vecchia, C., Johnson, C. D., Biankin, A. V., Neale, R. E., Tempero, M., Tuveson, D. A., Hruban, R. H., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.22 · Cited by 1,982
Pancreatic cancers require autophagy for tumor growth
Yang, S., Wang, X., Contino, G., Liesa, M., Sahin, E., Ying, H., Bause, A., Li, Y., Stommel, J. M., Dell'Antonio, G., et al. (2011) · Genes & Development · doi:10.1101/gad.2016111 · Cited by 1,498
Self-citation
Metadata
- Authors
- Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2006-05-15
- Volume
- 20
- Issue
- 10
- Pages
- 1218-1249
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2099023480
- Cited by
- 1,577
- References
- 428
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.